How digital health and clinical platforms are bringing Galleri into real-world care
Multi-cancer early detection (MCED) represents one of the most important shifts happening in preventative care. Blood-based tests like the Galleri® multi-cancer early detection test open the door to identifying a signal for cancer early – including for many cancers without recommended screening options today.
But bringing advanced cancer screening like Galleri into real-world care models requires more than availability. It requires operational infrastructure.
Over the past year, we’ve seen growing demand from digital health platforms, longevity clinics, and employer-based care programs looking to incorporate MCED into their workflows. The common challenge isn’t clinical interest – it’s execution.
Here’s what it actually takes to operationalize multi-cancer early detection at scale.
1. Complexity Starts Long Before the Order
For most organizations, the complexity of the Galleri test begins before a test is ever ordered.
Teams must align on:
Unlike routine cancer screenings, MCED tests require thoughtful positioning inside care pathways. Organizations must determine where the Galleri test fits – annual wellness programs, proactive screening offerings, executive health workflows, or risk-stratified care models.
Without structured workflows, adoption quickly becomes inconsistent.
2. Ordering Is Only One Piece of the Workflow
Ordering a Galleri test is straightforward. Operationalizing it across an organization is not.
Teams must account for:
These are solvable problems individually – but together, they introduce friction that slows adoption and strains operations teams.
We consistently see organizations underestimate the lift required to support complex testing across distributed care environments.
3. Results Workflows Matter More Than Expected
MCED testing introduces unique downstream considerations:
Organizations quickly discover that results management – not ordering – is often the hardest part to scale.
Without structured workflows, clinical teams face inconsistent processes and operational bottlenecks.
4. Infrastructure Determines Adoption
As advanced diagnostics move into mainstream care, infrastructure will increasingly determine which innovations scale.
Organizations that successfully implement MCED testing typically rely on:
At Junction, we focus on enabling these operational layers so organizations can integrate the Galleri test into care delivery without rebuilding workflows from scratch.
5. Where We’re Seeing Galleri Gain Traction
We’re seeing strong interest across:
Longevity and preventative care platforms
Organizations offering proactive health programs are incorporating Galleri as part of broader screening strategies.
Concierge and employer-based care models
These environments often move fastest due to aligned incentives and patient demand.
Digital health platforms
Virtual-first organizations are integrating MCED testing into hybrid care pathways.
In each case, success depends less on clinical demand and more on operational readiness.
Looking Ahead
Multi-cancer early detection is still early, but momentum is clear. As organizations expand preventative offerings, the focus is shifting from whether to offer MCED testing to how to operationalize it effectively.
We believe infrastructure will play a defining role in how quickly innovations like Galleri reach patients.
If your team is exploring how to integrate Galleri into your workflows, we’d love to share what we’re seeing across the market.
Contact us: sales@junction.com